Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

But approximately one-third of agricultural lands have been degraded by industrial agriculture: boosting yield through ...

The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, ...

We speak to future food investor Heather Courtney, general partner at Alwyn Capital, about alternative proteins and the ...

Bühler aims to foster the development of equipment to enable market-ready, sustainable, healthy and affordable cellular ...

Have a great idea for a new food product but unsure how to bring it to market? Aspiring food entrepreneurs in Shasta, Trinity ...

When navigating the new product development process, Clemens’ approach is that pork consumers are always seeking ...

Following a rigorous review of pitches from applicants, Kresko RNAtech has been selected as the winner for its outstanding commitment to advancing the science behind dietary supplements and functional ...

We are honored to celebrate the expansion of this iconic local business in Jefferson Parish,” said Jefferson Parish President ...

MARSHFIELD, WIS. — Nelson-Jameson, a distributor for the food processing industry, and Gourmet Ingredients, a culinary food industry supplier of clean label ingredients formulated from onions, ...